For the Inventor, By the Inventor

Enter assignee name

Ann Arbor, MI, United States of America

Lycera Corporation

USPTO Granted Patents = 36

% Expired Patents = 72.2

CIPO Patents = 3

EPO Patents = 9

Forward Citations = 222

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Thomas Daniel Aicher (23 out of 53 patents)

Clarke Bentley Taylor (21 out of 30 patents)

Chad A VanHuis (14 out of 15 patents)

4. Peter Laurence Toogood (14 out of 32 patents)

5. Chad A Van Huis (12 out of 12 patents)

6. Alexander Ross Hurd (12 out of 16 patents)

7. Vladimir Simov (8 out of 13 patents)

8. Kenneth Jay Barr (8 out of 44 patents)

9. William L Thomas (7 out of 265 patents)

10. Catherine M White (7 out of 19 patents)

11. Gary D Glick (7 out of 66 patents)

12. Blair T Lapointe (6 out of 18 patents)

13. Donald James Skalitzky (6 out of 8 patents)

14. Nunzio Sciammetta (5 out of 24 patents)

15. Matthew H Daniels (5 out of 19 patents)

Core Competencies:

Tetrahydronaphthyridine

Benzoxazine

RORgamma

Thiadiazolamines

Dihydro-2H-benzo[b][1,4]oxazine

Aryl Dihydro-2H-benzo[b][1,4]oxazine

Sulfonamide

Agonists

Inhibition

Therapeutic Methods

Bicyclic Compounds

36 patents: Sort by Forward Citations

1. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2020-08-18),

2. 10611740 - Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2020-04-07),

3. 10556898 - Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease (2020-02-11),

4. 10532088 - Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods (2020-01-14),

5. 10442798 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-10-15),

6. 10421751 - Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-09-24),

7. 10392350 - N-substituted pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof (2019-08-27),

8. 10377768 - Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-08-13),

9. 10364237 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-07-30),

10. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-03-05),

11. 10208061 - Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-02-19),

12. 10189777 - Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease (2019-01-29),

13. 10112935 - Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease (2018-10-30),

14. 10085972 - [object Object] (2018-10-02),

15. 9932313 - [object Object] (2018-04-03),

Company Overview

Lycera Corporation, based in Ann Arbor, MI, is a biopharmaceutical company focused on developing innovative therapies for autoimmune diseases and cancer. The organization specializes in the discovery and advancement of small molecule drugs that modulate immune responses, leveraging its expertise in immunology and drug design. Lycera's research aims to address significant unmet medical needs through targeted treatments, contributing to the evolving landscape of precision medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

36 Patents

#24 in Ann Arbor, MI

#361 in Michigan

#9,502 in US

#18,716 in the World

Ann Arbor, MI, United States of America

Lycera Corporation

Forward Citations = 222

35 inventors:

Thomas Daniel Aicher (23 out of 53 patents)

Clarke Bentley Taylor (21 out of 30 patents)

Chad A VanHuis (14 out of 15 patents)

4. Peter Laurence Toogood (14 out of 32 patents)

5. Chad A Van Huis (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lycera Corporation. Retrieved from https://idiyas.com/company/lycera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…